Document Detail


Mimetics of L-histidinol which selectively modulate daunomycin toxicity in normal and tumorigenic epithelial cells.
MedLine Citation:
PMID:  9042234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the accompanying publication, it was shown that L-histidinol protected the normal Madin-Darby canine kidney (MDCK) epithelial cell line from daunomycin (DAU) toxicity, but enhanced DAU toxicity in MDCK-T1, a tumorigenic derivative of MDCK. The protection of MDCK cells from DAU by L-histidinol was also shown to be independent of its ability to inhibit protein synthesis. Here, clonogenic cell survival assays show that imidazole was as effective as L-histidinol in protecting MDCK cells from DAU, but had less impact on MDCK-T1 line. Certain antieicosanoids and antihistamines mimicked, to varying extents, the DAU-modulating action of L-histidinol. These data suggest that the selective modulation of DAU toxicity by L-histidinol involves both inhibition of protein synthesis and unknown action(s) attributable to its imidazole moiety and that other pharmacological agents are modulators of anticancer drug toxicity.
Authors:
R C Warrington; W D Fang; L Zhang; M Shieh; M H Saier
Related Documents :
11988104 - High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by r...
9719484 - The relationship between modulation of mdr and glutathione in mrp-overexpressing human ...
8995514 - Comparative activity of idarubicin and idarubicinol in combination with cyclosporin a i...
17451894 - Both p-gp and mrp2 mediate transport of lopinavir, a protease inhibitor.
9133384 - Proliferation in the rat olfactory epithelium: age-dependent changes.
21076414 - Competition amongst eph receptors regulates contact inhibition of locomotion and invasi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  16     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1996 Nov-Dec
Date Detail:
Created Date:  1997-03-27     Completed Date:  1997-03-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  3635-9     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibiotics, Antineoplastic / pharmacology*
Cell Line / drug effects
Daunorubicin / pharmacology*
Dogs
Drug Interactions
Eicosanoids / antagonists & inhibitors*
Histamine H1 Antagonists / pharmacology*
Histidinol / pharmacology*
Imidazoles / pharmacology*
Protein Synthesis Inhibitors / pharmacology
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Eicosanoids; 0/Histamine H1 Antagonists; 0/Imidazoles; 0/Protein Synthesis Inhibitors; 20830-81-3/Daunorubicin; 501-28-0/Histidinol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  L-histidinol selectively modulates daunomycin toxicity in normal and tumorigenic kidney epithelial c...
Next Document:  L-histidinol reverses resistance to cisplatinum and other antineoplastics in a tumorigenic epithelia...